"Amyloid beta-Peptides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue.
| Descriptor ID |
D016229
|
| MeSH Number(s) |
D12.644.024 D12.776.049.407.249.500 D12.776.543.039.500
|
| Concept/Terms |
Amyloid beta-Peptides- Amyloid beta-Peptides
- Amyloid beta Peptides
- beta-Peptides, Amyloid
- Alzheimer's ABP
- ABP, Alzheimer's
- Alzheimer ABP
- Alzheimers ABP
- Alzheimer's Amyloid Fibril Protein
- Amyloid AD-AP
- AD-AP, Amyloid
- Amyloid AD AP
- beta-Amyloid Protein
- Protein, beta-Amyloid
- beta Amyloid Protein
- Amyloid beta-Protein
- Amyloid beta Protein
- beta-Protein, Amyloid
- Amyloid beta-Proteins
- Amyloid beta Proteins
- beta-Proteins, Amyloid
- Amyloid Fibril Protein, Alzheimer's
- Amyloid Protein A4
- Protein A4, Amyloid
- Alzheimer beta-Protein
- Alzheimer beta Protein
- beta-Protein, Alzheimer
- Amyloid beta-Peptide
- Amyloid beta Peptide
- beta-Peptide, Amyloid
|
Below are MeSH descriptors whose meaning is more general than "Amyloid beta-Peptides".
Below are MeSH descriptors whose meaning is more specific than "Amyloid beta-Peptides".
This graph shows the total number of publications written about "Amyloid beta-Peptides" by people in this website by year, and whether "Amyloid beta-Peptides" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 11 | 3 | 14 |
| 1996 | 13 | 6 | 19 |
| 1997 | 10 | 3 | 13 |
| 1998 | 17 | 3 | 20 |
| 1999 | 14 | 4 | 18 |
| 2000 | 25 | 7 | 32 |
| 2001 | 21 | 6 | 27 |
| 2002 | 33 | 9 | 42 |
| 2003 | 38 | 16 | 54 |
| 2004 | 31 | 11 | 42 |
| 2005 | 47 | 18 | 65 |
| 2006 | 52 | 24 | 76 |
| 2007 | 38 | 19 | 57 |
| 2008 | 47 | 21 | 68 |
| 2009 | 61 | 28 | 89 |
| 2010 | 65 | 35 | 100 |
| 2011 | 70 | 31 | 101 |
| 2012 | 70 | 33 | 103 |
| 2013 | 56 | 46 | 102 |
| 2014 | 57 | 25 | 82 |
| 2015 | 63 | 37 | 100 |
| 2016 | 57 | 30 | 87 |
| 2017 | 67 | 37 | 104 |
| 2018 | 47 | 38 | 85 |
| 2019 | 44 | 49 | 93 |
| 2020 | 56 | 62 | 118 |
| 2021 | 36 | 78 | 114 |
| 2022 | 19 | 119 | 138 |
| 2023 | 20 | 135 | 155 |
| 2024 | 55 | 83 | 138 |
| 2025 | 1 | 6 | 7 |
Below are the most recent publications written about "Amyloid beta-Peptides" by people in Profiles.
-
Early Alzheimer's Disease with frequent neuritic plaques harbors neocortical tau seeds distinct from primary age-related tauopathy. Nat Commun. 2025 Feb 21; 16(1):1851.
-
Alzheimer Disease Blood Biomarkers and Cognition Among Individuals With Diabetes and Overweight or Obesity. JAMA Netw Open. 2025 Feb 03; 8(2):e2458149.
-
Disclosure of elevated amyloid status is not associated with long-term suicidality in a preclinical AD trial. Alzheimers Dement. 2025 Feb; 21(2):e14623.
-
Association of Medial Temporal Lobe Cerebrovascular Reactivity and Memory Function in Older Adults With and Without Cognitive Impairment. Neurology. 2025 Jan 14; 104(1):e210210.
-
Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer's disease. Brain. 2025 Jan 07; 148(1):119-132.
-
Amyloid, Tau, and APOE in Alzheimer's Disease: Impact on White Matter Tracts. Pac Symp Biocomput. 2025; 30:394-411.
-
Expert opinion on Centiloid thresholds suitable for initiating anti-amyloid therapy. Summary of discussion at the 2024 spring Alzheimer's Association Research Roundtable. J Prev Alzheimers Dis. 2025 Jan; 12(1):100008.
-
Spatial proteomic differences in chronic traumatic encephalopathy, Alzheimer's disease, and primary age-related tauopathy hippocampi. Alzheimers Dement. 2025 Feb; 21(2):e14487.
-
Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinics. EBioMedicine. 2025 Feb; 112:105504.
-
Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease. Neurology. 2025 Jan 14; 104(1):e210152.